Rivalry between over who calls the shots is threatening to spill into the open just when the European Union is trying to close ranks in the face of mounting challenges: Here's your Evening Briefing https://t.co/a93166rYZF ...

Carlos Alcaraz and Jannik Sinner are the sport’s next great rivalry—on and off the court—as they lead a group of 10 stars who collectively earned $285 million over the past year.https://t.co/FlT5g4PQoOhttps://t.co/FlT5g4PQoO ...

Carlos Alcaraz and Jannik Sinner are the sport’s next great rivalry—on and off the court—as they lead a group of 10 stars who collectively earned $285 million over the past year.Read more: https://t.co/RmtYeK98qM https://t.co/lAxEJjwjVC ...

Carlos Alcaraz and Jannik Sinner are the sport’s next great rivalry—on and off the court—as they lead a group of 10 stars who collectively earned $285 million over the past year.Read more: https://t.co/RmtYeK98qM https://t.co/uwAmtnUiYb ...

The legendary Maria Sherupova accepting her induction into the International Tennis Hall of Fame this weekend. >> When voices inevitably tell you to ease up, to round your edges, I hope you can find a way to ignore them. Compete fiercely, raise your standard, and don't forget to celebrate your victories, no matter how small.The fivetime Grand Slam winner cemented her legacy on the court alongside some of the biggest names in sports. Maria is one of only 10 women in tennis history to achieve a career singles ...

The Prompt: Sam Altman Escalates Rivalry With Elon Musk https://t.co/iwKR0qYFBB https://t.co/abU92ZCmF6 ...

The Prompt: Sam Altman Escalates Rivalry With Elon Musk https://t.co/NMqk0R5H3f https://t.co/ZNS9CniQBA ...

The Prompt: Sam Altman Escalates Rivalry With Elon Muskhttps://t.co/wWknMCv861 https://t.co/j7WGw0twqs ...

India has long placed great weight on the notion that America and China are locked in a contest that could last decades. Now its elites are unsure how heavily that rivalry weighs on Donald Trump https://t.co/z173E46JM6 ...

Market Competition - Novo Nordisk and Eli Lilly, dominating the global obesity drug market, encounter their first serious rival in China [1]